Dialysis Market Size and Share | Statistics

Name: Dialysis Market Size and Share | Statistics – 2030
Creator: Next Move Strategy Consulting
Published: 2025-07-18T05:30:00+05:30

Dialysis Market by Modality (Hemodialysis (HD), and Peritoneal Dialysis (PD)), and by End User (Hospitals, Dialysis Centers, Homecare, and Ambulatory Surgical Centers) – Global Opportunity Analysis and Industry Forecast, 2024–2030

Download PDF

Speak to Our Analyst

Market Overview

The global Dialysis Market size was valued at USD 111.74 billion in 2023 and is predicted to reach USD 145.07 billion by 2030, with a CAGR of 3.80% from 2024 to 2030. Dialysis refers to the global healthcare sector focused on the provision of artificial kidney functions to individuals suffering from impaired renal function.

Dialysis is a life-sustaining medical procedure employed to manage patients with end-stage renal disease (ESRD) or acute kidney injuries. This market encompasses a spectrum of products and services, including hemodialysis and peritoneal dialysis equipment, dialysis consumables, and associated pharmaceuticals. With the rising prevalence of kidney-related disorders and the increasing aging population globally, the dialysis market plays a critical role in delivering essential renal care, aiming to enhance patients' quality of life and improve overall healthcare outcomes.

Rising CKD Burden Fuels Global Surge in Dialysis Demand

The escalating global burden of chronic kidney disease is a primary force accelerating the dialysis market. Factors such as sedentary lifestyles, poor dietary habits, rising obesity rates, and the increasing prevalence of diabetes and hypertension are contributing to a sharp rise in CKD cases worldwide. As these underlying health conditions become more widespread, the demand for renal replacement therapies, particularly dialysis, has intensified. Moreover, enhanced screening programs, better diagnostic tools, and growing awareness among patients have led to earlier detection of kidney dysfunction, allowing for timely medical intervention. This shift towards proactive healthcare management is fueling the adoption of dialysis, especially in regions with limited access to kidney transplants, solidifying its role as a critical life-sustaining treatment.

Aging Demographics Accelerate Long-Term Dialysis Dependency

The steadily increasing global aging population is another pivotal driver of dialysis market growth. Aging naturally impairs kidney function, and older adults are more susceptible to chronic conditions such as diabetes, cardiovascular diseases, and hypertension—key risk factors for CKD. As a result, a substantial segment of the elderly population progresses to advanced stages of kidney failure, requiring continuous dialysis to maintain quality of life. Additionally, advancements in medical technology have extended life expectancy, meaning more individuals are living longer with chronic illnesses that necessitate ongoing dialysis support. This demographic trend, combined with a rising prevalence of age-associated comorbidities, continues to elevate the global demand for dialysis services, positioning the treatment as an indispensable component of modern renal care.

Limited Awareness Delaying Diagnosis and Dialysis Uptake

A major challenge restraining the growth of the global dialysis market is the widespread lack of awareness about kidney diseases. Many individuals remain uninformed about early symptoms, risk factors, and the critical role of dialysis in managing chronic kidney conditions. This knowledge gap leads to delayed diagnosis and treatment, limiting demand for dialysis services worldwide. Enhancing global awareness through focused education and outreach is essential to promote early detection, timely care, and sustainable market growth.

Wearable Dialysis Tech Unlocks the Future of Renal Care

The global dialysis market is poised for a significant transformation with the rise of wearable and portable dialysis devices. These innovative technologies are redefining patient care by offering enhanced mobility, convenience, and flexibility beyond traditional in-clinic treatments. As compact, user-friendly systems gain traction worldwide, they open new avenues for personalized and continuous dialysis therapy. This evolution not only improves quality of life for patients but also drives market expansion through technological breakthroughs, increased adoption, and a shift toward home-based care solutions—heralding a new era of innovation and growth in the dialysis landscape.

North America dominates the dialysis market

The prevalence of chronic kidney disease (CKD) is on the rise in the region, attributed to factors such as high incidence of diabetes and hypertension. This escalating CKD prevalence contributes to an increased demand for dialysis services. According to the Centre for Disease Control and Prevention, more than 14% of the U.S. population, equivalent to an estimated 35.5 million individuals, are affected by chronic kidney disease.

In addition, the growing advancement in the region by organizations investing in research and development, clinical trials, and strategic collaborations further catalyzes the dynamism of the North America dialysis market. These concerted efforts foster the introduction of cutting-edge technologies, novel therapies, and treatment modalities, contributing significantly to the expansion and improvement of dialysis services.

The collaborative initiatives and research endeavors enhance the overall efficacy of dialysis treatments, ensuring that the North American market remains at the forefront of innovation, addressing the evolving needs of patients with kidney-related disorders. This commitment to progress strengthens the region's position as a key driver in the global dialysis market landscape.

For instance, KidneyX represents a public-private partnership between the American Society of Nephrology (ASN) and the U.S. Department of Health and Human Services (HHS). The partnership launched a prototype based on an artificial kidney. The project combined the two essential parts of its artificial kidney, the hemofilter and the bioreactor, and successfully implanted the smartphone-sized device for preclinical evaluation. Thus, the ongoing efforts to develop artificial kidneys hold tremendous promise in revolutionizing the treatment of kidney-related conditions.

Asia-Pacific is expected to show steady growth in the dialysis market

Asia-Pacific is expected to witness an increase in demand for dialysis services, primarily driven by its rapidly growing aging population. The demographic shift towards an older population in the region contributes significantly to the rising prevalence of chronic kidney disease (CKD) and other kidney-related disorders. As individuals age, the incidence of kidney dysfunction tends to increase, leading to a greater demand for renal replacement therapies that include dialysis. The expanding elderly demographic, coupled with lifestyle changes and a higher prevalence of conditions such as diabetes and hypertension, amplifies the need for effective and accessible dialysis treatments.

The Asia-Pacific region is poised to experience a surge in demand for dialysis services as healthcare systems strive to address the specific healthcare requirements of the aging population, thereby shaping the growth trajectory of the dialysis market in the region. According to the National Library of Medicine, the proportion of individuals aged 60 years and above in China is projected to rise from 12.4% (168 million) to 28% (402 million) by 2040.

Competitive Landscape

Several market players operating in the dialysis industry include Fresenius Medical Care AG And Co. KGaA, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation., Asahi Kasei Corporation, Becton, Dickinson and Company (BD), Medtronic Plc, Teleflex Incorporated, Toray Medical Co., Ltd. (Toray Industries, Inc.), Nikkiso Co., Ltd., Dialife SA,, Rockwell Medical, Inc. W. L. Gore and Associates, Inc., Quanta Dialysis Technologies Ltd., Outset Medical, Inc., Shandong Weigao Blood Purification Products Co., Ltd., JMS Co., Ltd., Medivators Inc., Terumo Corporation, SWS Hemodialysis Care Co., Ltd., and others are provided in the dialysis market report.

For instance, in April 2023, Medtronic plc and DaVita Inc. unveiled Mozarc Medical, a new independent company dedicated to transforming kidney health through patient-centric technology solutions. Mozarc Medical aims to pioneer innovative kidney health technologies that enhance the overall patient experience and promote global access to care.

In addition, in August 2022, Fresenius Medical Care North America's Renal Therapies Group introduced Speedswap, an innovative option for the NxStage System One with NxView. This technology allows for the replacement of a flow-compromised dialysis filter without changing the entire cartridge, aiming to minimize therapy downtime, streamline nursing tasks, and cut treatment costs in acute care settings.

Moreover, in June 2021, Baxter International Inc. introduced Sharesource Analytics 1.0, a cutting-edge digital health solution for home-based peritoneal dialysis (PD) patients. This clinical management resource, part of the Sharesource platform, offers healthcare professionals a simplified dashboard with trend data from patients' home dialysis treatments.

Dialysis Market Key Segments:

By Modality

Hemodialysis (HD)
- Hemodialysis Machines
  - In-center HD
  - Home HD
- Water Treatment Systems
  - Central water-disinfection units
  - Point-of-use/portable systems
- Ancillary/Other HD Equipment
  - UF/ultrafiltration pumps
  - Dialysis chairs/beds
  - Disinfection/sterilization units
  - Monitoring & data-capture hardware
- HD Consumables & Supplies
  - Dialyzers
  - Bloodlines & Tubing Sets
  - Dialysis Fluids / Concentrates
  - Vascular Access Products
  - Other HD Consumables & Accessories
- HD Aftermarket Services
  - Repair & Maintenance
  - Installation & Commissioning
  - Training & Technical Support
Peritoneal Dialysis (PD)
- PD Cyclers / Automated PD Machines
- Ancillary PD Equipment
- PD Consumables & Supplies
  - PD Dialysis Solutions
  - PD Catheters & Access Systems
  - Transfer Sets & Tubing
  - Other PD Supplies / Accessories
- PD Aftermarket Services
  - Repair & Maintenance (Cyclers & Heaters)
  - Installation & Commissioning
  - Training & Technical Support

By End-User

Hospitals
Dialysis Centers
Homecare
Ambulatory Surgical Centers

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- Taiwan
- South Korea
- Rest of Asia-Pacific
Rest of the World (RoW)
- Saudi Arabia
- South Africa
- Brazil
- Remaining Countries

Key Players:

Fresenius Medical Care AG And Co. KGaA
Baxter International Inc.
B. Braun Melsungen AG
Nipro Corporation
Asahi Kasei Corporation
Becton, Dickinson and Company (BD)
Medtronic Plc
Teleflex Incorporated
Toray Medical Co., Ltd. (Toray Industries, Inc.)
Nikkiso Co., Ltd.
Dialife SA
Rockwell Medical, Inc.
W. L. Gore and Associates, Inc.
Quanta Dialysis Technologies Ltd.
Outset Medical, Inc.
Shandong Weigao Blood Purification Products Co., Ltd.
JMS Co., Ltd.
Medivators Inc.
Terumo Corporation
SWS Hemodialysis Care Co., Ltd.

REPORT SCOPE AND SEGMENTATION:

Parameters	Details
Market Size in 2023	USD 111.74 Billion
Revenue Forecast in 2030	USD 145.07 Billion
Growth Rate	CAGR of 3.80% from 2024 to 2030
Analysis Period	2023–2030
Base Year Considered	2023
Forecast Period	2024–2030
Market Size Estimation	Billion (USD)
Growth Factors	Rising CKD Burden Fuels Global Surge in Dialysis Demand Aging Demographics Accelerate Long-Term Dialysis Dependency
Countries Covered	18
Companies Profiled	20
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.

1. 1.1. REPORT DESCRIPTION
2. 1.2. WHO SHOULD READ THIS REPORT
3. 1.3. KEY MARKET SEGMENTS
4. 1.4. KEY MARKET PLAYERS
5. 1.5. RESEARCH METHODOLOGY
6. 1. 1.5.1 MARKET SIZE ESTIMATION METHODOLOGY
  2. 1. 1.5.1.1 TOP-DOWN AND BOTTOM-UP APPROACH
    2. 1.5.1.2 REVENUE BREAKDOWN OF TOP 10 COMPANIES IN DIALYSIS MARKET (2024)
    3. 1.5.1.3 DEMAND AND SUPPLY-SIDE ANALYSIS
    4. 1.5.1.4 MACRO-INDICATOR APPROACH
  3. 1.5.2 DATA COLLECTION APPROACH
  4. 1. 1.5.2.1 PRIMARY DATA COLLECTION
    2. 1.5.2.2 SECONDARY DATA COLLECTION
    3. 1. 1.5.2.2.1 SECONDARY DATA SOURCES
  5. 1.5.3 FORECASTING

1. 2.1. DEFINITION
2. 2.2. SCOPE

1. 3.1. MARKET SNAPSHOT, 2024 - 2030, MILLION USD

1. 4.1. MARKET DYNAMICS
2. 1. 4.1.1 DRIVERS
  2. 1. 4.1.1.1 RISING CKD BURDEN FUELS GLOBAL SURGE IN DIALYSIS DEMAND
    2. 4.1.1.2 AGING DEMOGRAPHICS ACCELERATE LONG-TERM DIALYSIS DEPENDENCY
  3. 4.1.2 RESTRAINTS
  4. 1. 4.1.2.1 LIMITED AWARENESS DELAYING DIAGNOSIS AND DIALYSIS UPTAKE
  5. 4.1.3 OPPORTUNITIES
  6. 1. 4.1.3.1 WEARABLE DIALYSIS TECH UNLOCKS THE FUTURE OF RENAL CARE

1. 5.1. MARKET SHARE ANALYSIS OF TOP 10 DIALYSIS PROVIDERS, 2024

1. 6.1 OVERVIEW
2. 6.2 HEMODIALYSIS (HD)
3. 1. 6.2.1 GLOBAL HEMODIALYSIS (HD) MARKET, BY MODALITY
  2. 1. 6.2.1.1 HEMODIALYSIS MACHINES MARKET, BY REGION
    2. 1. 6.2.1.1.1 IN-CENTER HD
      2. 6.2.1.1.2 HOME HD
      3. 6.2.1.1.1.1 NORTH AMERICA HEMODIALYSIS MACHINES MARKET, BY COUNTRY
        6.2.1.1.1.2 EUROPE HEMODIALYSIS MACHINES MARKET, BY COUNTRY
        6.2.1.1.1.3 ASIA-PACIFIC HEMODIALYSIS MACHINES MARKET, BY COUNTRY
        6.2.1.1.1.4 REST OF THE WORLD HEMODIALYSIS MACHINES MARKET, BY COUNTRY
    3. 6.2.1.2 WATER TREATMENT SYSTEMS MARKET, BY REGION
    4. 1. 6.2.1.2.1 CENTRAL WATER-DISINFECTION UNITS
      2. 6.2.1.2.2 POINT-OF-USE/PORTABLE SYSTEMS
      3. 6.2.1.2.1.1 NORTH AMERICA WATER TREATMENT SYSTEMS MARKET, BY COUNTRY
        6.2.1.2.1.2 EUROPE WATER TREATMENT SYSTEMS MARKET, BY COUNTRY
        6.2.1.2.1.3 ASIA-PACIFIC WATER TREATMENT SYSTEMS MARKET, BY COUNTRY
        6.2.1.2.1.4 REST OF THE WORLD WATER TREATMENT SYSTEMS MARKET, BY COUNTRY
    5. 6.2.1.3 ANCILLARY/OTHER HD EQUIPMENT MARKET, BY REGION
    6. 1. 6.2.1.3.1 UF/ULTRAFILTRATION PUMPS
      2. 6.2.1.3.2 DIALYSIS CHAIRS/BEDS
      3. 6.2.1.3.3 DISINFECTION/STERILIZATION UNITS
      4. 6.2.1.3.4 MONITORING & DATA-CAPTURE HARDWARE
      5. 6.2.1.3.1.1 NORTH AMERICA ANCILLARY/OTHER HD EQUIPMENT MARKET, BY COUNTRY
        6.2.1.3.1.2 EUROPE ANCILLARY/OTHER HD EQUIPMENT MARKET, BY COUNTRY
        6.2.1.3.1.3 ASIA-PACIFIC ANCILLARY/OTHER HD EQUIPMENT MARKET, BY COUNTRY
        6.2.1.3.1.4 REST OF THE WORLD ANCILLARY/OTHER HD EQUIPMENT MARKET, BY COUNTR
    7. 6.2.1.4 HD CONSUMABLES AND SUPPLIES MARKET, BY REGION
    8. 1. 6.2.1.4.1 DIALYZERS
      2. 6.2.1.4.2 BLOODLINES & TUBING SETS
      3. 6.2.1.4.3 DIALYSIS FLUIDS / CONCENTRATES
      4. 6.2.1.4.4 VASCULAR ACCESS PRODUCTS
      5. 6.2.1.4.5 OTHER HD CONSUMABLES & ACCESSORIES
      6. 6.2.1.4.1.1 NORTH AMERICA HD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
        6.2.1.4.1.2 EUROPE HD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
        6.2.1.4.1.3 ASIA-PACIFIC HD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
        6.2.1.4.1.3 REST OF THE WORLD HD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
    9. 6.2.1.5 HD AFTERMARKET SERVICES MARKET, BY REGION
    10. 1. 6.2.1.5.1 REPAIR & MAINTENANCE
      2. 6.2.1.5.2 INSTALLATION & COMMISSIONING
      3. 6.2.1.5.3 TRAINING & TECHNICAL SUPPORT
      4. 6.2.1.5.1.1 NORTH AMERICA HD AFTERMARKET SERVICES MARKET, BY COUNTRY
        6.2.1.5.1.2 EUROPE HD AFTERMARKET SERVICES MARKET, BY COUNTRY
        6.2.1.5.1.3 ASIA-PACIFIC HD AFTERMARKET SERVICES MARKET, BY COUNTRY
        6.2.1.5.1.4 REST OF THE WORLD HD AFTERMARKET SERVICES MARKET, BY COUNTRY
  3. 6.2.2 HEMODIALYSIS (HD) MARKET, BY REGION
  4. 1. 6.2.2.1 NORTH AMERICA HEMODIALYSIS (HD) MARKET, BY COUNTRY
    2. 6.2.2.2 EUROPE HEMODIALYSIS (HD) MARKET, BY COUNTRY
    3. 6.2.2.3 ASIA-PACIFIC HEMODIALYSIS (HD) MARKET, BY COUNTRY
    4. 6.2.2.4 REST OF THE WORLD HEMODIALYSIS (HD) MARKET, BY COUNTRY
4. 6.3 PERITONEAL DIALYSIS (PD)
5. 1. 6.3.1 GLOBAL PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
  2. 1. 6.3.1.1 PD CYCLERS / AUTOMATED PD MACHINES MARKET, BY REGION
    2. 1. 6.3.1.1.1 NORTH AMERICA PD CYCLERS / AUTOMATED PD MACHINES MARKET, BY COUNTRY
      2. 6.3.1.1.2 EUROPE PD CYCLERS / AUTOMATED PD MACHINES MARKET, BY COUNTRY
      3. 6.3.1.1.3 ASIA-PACIFIC PD CYCLERS / AUTOMATED PD MACHINES MARKET, BY COUNTRY
      4. 6.3.1.1.4 REST OF THE WORLD PD CYCLERS / AUTOMATED PD MACHINES MARKET, BY COUNTRY
    3. 6.3.1.2 ANCILLARY PD EQUIPMENT MARKET, BY REGION
    4. 1. 6.3.1.2.1 NORTH AMERICA ANCILLARY PD EQUIPMENT MARKET, BY COUNTRY
      2. 6.3.1.2.2 EUROPE ANCILLARY PD EQUIPMENT MARKET, BY COUNTRY
      3. 6.3.1.2.3 ASIA-PACIFIC ANCILLARY PD EQUIPMENT MARKET, BY COUNTRY
      4. 6.3.1.2.4 REST OF THE WORLD ANCILLARY PD EQUIPMENT MARKET, BY COUNTRY
    5. 6.3.1.3 PD CONSUMABLES AND SUPPLIES MARKET, BY REGION
    6. 1. 6.3.1.3.1 PD DIALYSIS SOLUTIONS
      2. 6.3.1.3.2 PD CATHETERS & ACCESS SYSTEMS
      3. 6.3.1.3.3 TRANSFER SETS & TUBING
      4. 6.3.1.3.4 OTHER PD SUPPLIES / ACCESSORIES
      5. 6.3.1.3.1.1 NORTH AMERICA PD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
        6.3.1.3.1.2 EUROPE PD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
        6.3.1.3.1.3 ASIA-PACIFIC PD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
        6.3.1.3.1.4 REST OF THE WORLD PD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
    7. 6.3.1.4 PD AFTERMARKET SERVICES MARKET, BY REGION
    8. 1. 6.3.1.4.1 REPAIR & MAINTENANCE (CYCLERS & HEATERS)
      2. 6.3.1.4.2 INSTALLATION & COMMISSIONING
      3. 6.3.1.4.3 TRAINING & TECHNICAL SUPPORT
      4. 6.3.1.4.1.1 NORTH AMERICA PD AFTERMARKET SERVICES MARKET, BY COUNTRY
        6.3.1.4.1.2 EUROPE PD AFTERMARKET SERVICES MARKET, BY COUNTRY
        6.3.1.4.1.3 ASIA-PACIFIC PD AFTERMARKET SERVICES MARKET, BY COUNTRY
        6.3.1.4.1.4 REST OF THE WORLD PD AFTERMARKET SERVICES MARKET, BY COUNTRY
  3. 6.3.2 PERITONEAL DIALYSIS (PD) MARKET, BY REGION
  4. 1. 6.3.2.1 NORTH AMERICA PERITONEAL DIALYSIS (PD) MARKET, BY COUNTRY
    2. 6.3.2.2 EUROPE PERITONEAL DIALYSIS (PD) MARKET, BY COUNTRY
    3. 6.3.2.3 ASIA-PACIFIC PERITONEAL DIALYSIS (PD) MARKET, BY COUNTRY
    4. 6.3.2.4 REST OF THE WORLD PERITONEAL DIALYSIS (PD) MARKET, BY COUNTRY

1. 7.1 OVERVIEW
2. 7.2 HOSPITALS
3. 1. 7.2.1 HOSPITALS MARKET, BY REGION
  2. 1. 7.2.1.1 NORTH AMERICA HOSPITALS MARKET, BY COUNTRY
    2. 7.2.1.2 EUROPE HOSPITALS MARKET, BY COUNTRY
    3. 7.2.1.3 ASIA-PACIFIC HOSPITALS MARKET, BY COUNTRY
    4. 7.2.1.4 REST OF THE WORLD HOSPITALS MARKET, BY COUNTRY
4. 7.3 DIALYSIS CENTERS
5. 1. 7.3.1 DIALYSIS CENTERS MARKET, BY REGION
  2. 1. 7.3.1.1 NORTH AMERICA DIALYSIS CENTERS MARKET, BY COUNTRY
    2. 7.3.1.2 EUROPE DIALYSIS CENTERS MARKET, BY COUNTRY
    3. 7.3.1.3 ASIA-PACIFIC DIALYSIS CENTERS MARKET, BY COUNTRY
    4. 7.3.1.4 REST OF THE WORLD DIALYSIS CENTERS MARKET, BY COUNTRY
6. 7.4 HOMECARE
7. 1. 7.4.1 HOMECARE MARKET, BY REGION
  2. 1. 7.4.1.1 NORTH AMERICA HOMECARE MARKET, BY COUNTRY
    2. 7.4.1.2 EUROPE HOMECARE MARKET, BY COUNTRY
    3. 7.4.1.3 ASIA-PACIFIC HOMECARE MARKET, BY COUNTRY
    4. 7.4.1.4 REST OF THE WORLD HOMECARE MARKET, BY COUNTRY
8. 7.5 AMBULATORY SURGICAL CENTERS
9. 1. 7.5.1 AMBULATORY SURGICAL CENTERS MARKET, BY REGION
  2. 1. 7.5.1.1 NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET, BY COUNTRY
    2. 7.5.1.2 EUROPE AMBULATORY SURGICAL CENTERS MARKET, BY COUNTRY
    3. 7.5.1.3 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS MARKET, BY COUNTRY
    4. 7.5.1.4 REST OF THE WORLD AMBULATORY SURGICAL CENTERS MARKET, BY COUNTRY

1. 8.1 OVERVIEW
2. 8.2 NORTH AMERICA
3. 1. 8.2.1 NORTH AMERICA DIALYSIS MARKET, BY MODALITY
  2. 1. 8.2.1.1 NORTH AMERICA HEMODIALYSIS (HD) MARKET, BY MODALITY
    2. 8.2.1.2 NORTH AMERICA PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
  3. 8.2.2 NORTH AMERICA DIALYSIS MARKET, BY END-USER
  4. 8.2.3 NORTH AMERICA DIALYSIS MARKET, BY COUNTRY
  5. 1. 8.2.3.1 UNITED STATES
    2. 1. 8.2.3.1.1 UNITED STATES DIALYSIS MARKET, BY MODALITY
      2. 8.2.3.1.1.1 UNITED STATES HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.2.3.1.1.2 UNITED STATES PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.2.3.1.2 UNITED STATES DIALYSIS MARKET, BY END-USER
    3. 8.2.3.2 CANADA
    4. 1. 8.2.3.2.1 CANADA DIALYSIS MARKET, BY MODALITY
      2. 8.2.3.2.1.1 CANADA HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.2.3.2.1.2 CANADA PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.2.3.2.2 CANADA DIALYSIS MARKET, BY END-USER
    5. 8.2.3.3 MEXICO
    6. 1. 8.2.3.3.1 MEXICO DIALYSIS MARKET, BY MODALITY
      2. 8.2.3.3.1.1 MEXICO HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.2.3.3.1.2 MEXICO PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.2.3.3.2 MEXICO DIALYSIS MARKET, BY END-USER
4. 8.3 EUROPE
5. 1. 8.3.1 EUROPE DIALYSIS MARKET, BY MODALITY
  2. 1. 8.3.1.1 EUROPE HEMODIALYSIS (HD) MARKET, BY MODALITY
    2. 8.3.1.2 EUROPE PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
  3. 8.3.2 EUROPE DIALYSIS MARKET, BY END-USER
  4. 8.3.3 EUROPE DIALYSIS MARKET, BY COUNTRY
  5. 1. 8.3.3.1 GERMANY
    2. 1. 8.3.3.1.1 GERMANY DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.1.1.1 GERMANY HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.1.1.2 GERMANY PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.1.2 GERMANY DIALYSIS MARKET, BY END-USER
    3. 8.3.3.2 FRANCE
    4. 1. 8.3.3.2.1 FRANCE DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.2.1.1 FRANCE HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.2.1.2 FRANCE PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.2.2 FRANCE DIALYSIS MARKET, BY END-USER
    5. 8.3.3.3 ITALY
    6. 1. 8.3.3.3.1 ITALY DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.3.1.1 ITALY HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.3.1.2 ITALY PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.3.2 ITALY DIALYSIS MARKET, BY END-USER
    7. 8.3.3.4 SPAIN
    8. 1. 8.3.3.4.1 SPAIN DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.4.1.1 SPAIN HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.4.1.2 SPAIN PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.4.2 SPAIN DIALYSIS MARKET, BY END-USER
    9. 8.3.3.5 UNITED KINGDOM
    10. 1. 8.3.3.5.1 UNITED KINGDOM DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.5.1.1 UNITED KINGDOM HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.5.1.2 UNITED KINGDOM PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.5.2 UNITED KINGDOM DIALYSIS MARKET, BY END-USER
    11. 8.3.3.6 RUSSIA
    12. 1. 8.3.3.6.1 RUSSIA DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.6.1.1 RUSSIA HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.6.1.2 RUSSIA PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.6.2 RUSSIA DIALYSIS MARKET, BY END-USER
    13. 8.3.3.7 SWITZERLAND
    14. 1. 8.3.3.7.1 SWITZERLAND DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.7.1.1 SWITZERLAND HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.7.1.2 SWITZERLAND PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.7.2 SWITZERLAND DIALYSIS MARKET, BY END-USER
    15. 8.3.3.8 SWEDEN
    16. 1. 8.3.3.8.1 SWEDEN DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.8.1.1 SWEDEN HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.8.1.2 SWEDEN PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.8.2 SWEDEN DIALYSIS MARKET, BY END-USER
    17. 8.3.3.9 NORWAY
    18. 1. 8.3.3.9.1 NORWAY DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.9.1.1 NORWAY HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.9.1.2 NORWAY PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.9.2 NORWAY DIALYSIS MARKET, BY END-USER
    19. 8.3.3.10 DENMARK
    20. 1. 8.3.3.10.1 DENMARK DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.10.1.1 DENMARK HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.10.1.2 DENMARK PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.10.2 DENMARK DIALYSIS MARKET, BY END-USER
    21. 8.3.3.11 FINLAND
    22. 1. 8.3.3.11.1 FINLAND DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.11.1.1 FINLAND HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.11.1.2 FINLAND PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.11.2 FINLAND DIALYSIS MARKET, BY END-USER
    23. 8.3.3.12 REST OF EUROPE
    24. 1. 8.3.3.12.1 REST OF EUROPE DIALYSIS MARKET, BY MODALITY
      2. 8.3.3.12.1.1 REST OF EUROPE HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.3.3.12.1.2 REST OF EUROPE PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.3.3.12.2 REST OF EUROPE DIALYSIS MARKET, BY END-USER
6. 8.4 ASIA-PACIFIC
7. 1. 8.4.1 ASIA-PACIFIC DIALYSIS MARKET, BY MODALITY
  2. 1. 8.4.1.1 ASIA-PACIFIC HEMODIALYSIS (HD) MARKET, BY MODALITY
    2. 8.4.1.2 ASIA-PACIFIC PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
  3. 8.4.2 ASIA-PACIFIC DIALYSIS MARKET, BY END-USER
  4. 8.4.3 ASIA-PACIFIC DIALYSIS MARKET, BY COUNTRY
  5. 1. 8.4.3.1 AUSTRALIA
    2. 1. 8.4.3.1.1 AUSTRALIA DIALYSIS MARKET, BY MODALITY
      2. 8.4.3.1.1.1 AUSTRALIA HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.4.3.1.1.2 AUSTRALIA PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.4.3.1.2 AUSTRALIA DIALYSIS MARKET, BY END-USER
    3. 8.4.3.2 CHINA
    4. 1. 8.4.3.2.1 CHINA DIALYSIS MARKET, BY MODALITY
      2. 8.4.3.2.1.1 CHINA HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.4.3.2.1.2 CHINA PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.4.3.2.2 CHINA DIALYSIS MARKET, BY END-USER
    5. 8.4.3.3 INDIA
    6. 1. 8.4.3.3.1 INDIA DIALYSIS MARKET, BY MODALITY
      2. 8.4.3.3.1.1 INDIA HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.4.3.3.1.2 INDIA PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.4.3.3.2 INDIA DIALYSIS MARKET, BY END-USER
    7. 8.4.3.4 JAPAN
    8. 1. 8.4.3.4.1 JAPAN DIALYSIS MARKET, BY MODALITY
      2. 8.4.3.4.1.1 JAPAN HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.4.3.4.1.2 JAPAN PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.4.3.4.2 JAPAN DIALYSIS MARKET, BY END-USER
    9. 8.4.3.5 SOUTH KOREA
    10. 1. 8.4.3.5.1 SOUTH KOREA DIALYSIS MARKET, BY MODALITY
      2. 8.4.3.5.1.1 SOUTH KOREA HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.4.3.5.1.2 SOUTH KOREA PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.4.3.5.2 SOUTH KOREA DIALYSIS MARKET, BY END-USER
    11. 8.4.3.6 INDONESIA
    12. 1. 8.4.3.6.1 INDONESIA DIALYSIS MARKET, BY MODALITY
      2. 8.4.3.6.1.1 INDONESIA HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.4.3.6.1.2 INDONESIA PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.4.3.6.2 INDONESIA DIALYSIS MARKET, BY END-USER
    13. 8.4.3.7 SINGAPORE
    14. 1. 8.4.3.7.1 SINGAPORE DIALYSIS MARKET, BY MODALITY
      2. 8.4.3.7.1.1 SINGAPORE HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.4.3.7.1.2 SINGAPORE PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.4.3.7.2 SINGAPORE DIALYSIS MARKET, BY END-USER
    15. 8.4.3.8 TAIWAN
    16. 1. 8.4.3.8.1 TAIWAN DIALYSIS MARKET, BY MODALITY
      2. 8.4.3.8.1.1 TAIWAN HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.4.3.8.1.2 TAIWAN PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.4.3.8.2 TAIWAN DIALYSIS MARKET, BY END-USER
    17. 8.4.3.9 THAILAND
    18. 1. 8.4.3.9.1 THAILAND DIALYSIS MARKET, BY MODALITY
      2. 8.4.3.9.1.1 THAILAND HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.4.3.9.1.2 THAILAND PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.4.3.9.2 THAILAND DIALYSIS MARKET, BY END-USER
    19. 8.4.3.10 REST OF ASIA-PACIFIC
    20. 1. 8.4.3.10.1 REST OF ASIA-PACIFIC DIALYSIS MARKET, BY MODALITY
      2. 8.4.3.10.1.1 REST OF ASIA-PACIFIC HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.4.3.10.1.2 REST OF ASIA-PACIFIC PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.4.3.10.2 REST OF ASIA-PACIFIC DIALYSIS MARKET, BY END-USER
8. 8.5 REST OF THE WORLD
9. 1. 8.5.1 REST OF THE WORLD DIALYSIS MARKET, BY MODALITY
  2. 1. 8.5.1.1 REST OF THE WORLD HEMODIALYSIS (HD) MARKET, BY MODALITY
    2. 8.5.1.2 REST OF THE WORLD PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
  3. 8.5.2 REST OF THE WORLD DIALYSIS MARKET, BY END-USER
  4. 8.5.3 REST OF THE WORLD DIALYSIS MARKET, BY COUNTRY
  5. 1. 8.5.3.1 LATIN AMERICA
    2. 1. 8.5.3.1.1 LATIN AMERICA DIALYSIS MARKET, BY MODALITY
      2. 8.5.3.1.1.1 LATIN AMERICA HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.5.3.1.1.2 LATIN AMERICA PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.5.3.1.2 LATIN AMERICA DIALYSIS MARKET, BY END-USER
    3. 8.5.3.2 MIDDLE EAST
    4. 1. 8.5.3.2.1 MIDDLE EAST DIALYSIS MARKET, BY MODALITY
      2. 8.5.3.2.1.1 MIDDLE EAST HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.5.3.2.1.2 MIDDLE EAST PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.5.3.2.2 MIDDLE EAST DIALYSIS MARKET, BY END-USER
    5. 8.5.3.3 AFRICA
    6. 1. 8.5.3.3.1 AFRICA DIALYSIS MARKET, BY MODALITY
      2. 8.5.3.3.1.1 AFRICA HEMODIALYSIS (HD) MARKET, BY MODALITY
        8.5.3.3.1.2 AFRICA PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
      3. 8.5.3.3.2 AFRICA DIALYSIS MARKET, BY END-USER

1. 9.1 FRESENIUS MEDICAL CARE AG AND CO. KGAA
2. 1. 9.1.1 COMPANY OVERVIEW
  2. 9.1.2 COMPANY SNAPSHOT
  3. 9.1.3 OPERATING BUSINESS SEGMENTS
  4. 9.1.4 PRODUCT PORTFOLIO
  5. 9.1.5 BUSINESS PERFORMANCE
  6. 9.1.6 BUSINESS SEGMENTS
  7. 9.1.7 GEOGRAPHIC SEGMENTS
  8. 9.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.1.9 PRIMARY MARKET COMPETITORS
3. 9.2 BAXTER INTERNATIONAL INC.
4. 1. 9.2.1 COMPANY OVERVIEW
  2. 9.2.2 COMPANY SNAPSHOT
  3. 9.2.3 OPERATING BUSINESS SEGMENTS
  4. 9.2.4 PRODUCT PORTFOLIO
  5. 9.2.5 BUSINESS PERFORMANCE
  6. 9.2.6 BUSINESS SEGMENTS
  7. 9.2.7 GEOGRAPHIC SEGMENTS
  8. 9.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.2.9 PRIMARY MARKET COMPETITORS
5. 9.3 B. BRAUN MELSUNGEN AG
6. 1. 9.3.1 COMPANY OVERVIEW
  2. 9.3.2 COMPANY SNAPSHOT
  3. 9.3.3 OPERATING BUSINESS SEGMENTS
  4. 9.3.4 PRODUCT PORTFOLIO
  5. 9.3.5 BUSINESS PERFORMANCE
  6. 9.3.6 BUSINESS SEGMENTS
  7. 9.3.7 GEOGRAPHIC SEGMENTS
  8. 9.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.3.9 PRIMARY MARKET COMPETITORS
7. 9.4 NIPRO CORPORATION
8. 1. 9.4.1 COMPANY OVERVIEW
  2. 9.4.2 COMPANY SNAPSHOT
  3. 9.4.3 OPERATING BUSINESS SEGMENTS
  4. 9.4.4 PRODUCT PORTFOLIO
  5. 9.4.5 BUSINESS PERFORMANCE
  6. 9.4.6 BUSINESS SEGMENTS
  7. 9.4.7 GEOGRAPHIC SEGMENTS
  8. 9.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.4.9 PRIMARY MARKET COMPETITORS
9. 9.5 ASAHI KASEI CORPORATION
10. 1. 9.5.1 COMPANY OVERVIEW
  2. 9.5.2 COMPANY SNAPSHOT
  3. 9.5.3 OPERATING BUSINESS SEGMENTS
  4. 9.5.4 PRODUCT PORTFOLIO
  5. 9.5.5 BUSINESS PERFORMANCE
  6. 9.5.6 BUSINESS SEGMENTS
  7. 9.5.7 GEOGRAPHIC SEGMENTS
  8. 9.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.5.9 PRIMARY MARKET COMPETITORS
11. 9.6 BECTON, DICKINSON AND COMPANY (BD)
12. 1. 9.6.1 COMPANY OVERVIEW
  2. 9.6.2 COMPANY SNAPSHOT
  3. 9.6.3 OPERATING BUSINESS SEGMENTS
  4. 9.6.4 PRODUCT PORTFOLIO
  5. 9.6.5 BUSINESS PERFORMANCE
  6. 9.6.6 BUSINESS SEGMENTS
  7. 9.6.7 GEOGRAPHIC SEGMENTS
  8. 9.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.6.9 PRIMARY MARKET COMPETITORS
13. 9.7 MEDTRONIC PLC
14. 1. 9.7.1 COMPANY OVERVIEW
  2. 9.7.2 COMPANY SNAPSHOT
  3. 9.7.3 OPERATING BUSINESS SEGMENTS
  4. 9.7.4 PRODUCT PORTFOLIO
  5. 9.7.5 BUSINESS PERFORMANCE
  6. 9.7.6 BUSINESS SEGMENTS
  7. 9.7.7 GEOGRAPHIC SEGMENTS
  8. 9.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.7.9 PRIMARY MARKET COMPETITORS
15. 9.8 TELEFLEX INCORPORATED
16. 1. 9.8.1 COMPANY OVERVIEW
  2. 9.8.2 COMPANY SNAPSHOT
  3. 9.8.3 OPERATING BUSINESS SEGMENTS
  4. 9.8.4 PRODUCT PORTFOLIO
  5. 9.8.5 BUSINESS PERFORMANCE
  6. 9.8.6 BUSINESS SEGMENTS
  7. 9.8.7 GEOGRAPHIC SEGMENTS
  8. 9.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.8.9 PRIMARY MARKET COMPETITORS
17. 9.9 TORAY MEDICAL CO., LTD. (TORAY INDUSTRIES, INC.)
18. 1. 9.9.1 COMPANY OVERVIEW
  2. 9.9.2 COMPANY SNAPSHOT
  3. 9.9.3 OPERATING BUSINESS SEGMENTS
  4. 9.9.4 PRODUCT PORTFOLIO
  5. 9.9.5 BUSINESS PERFORMANCE
  6. 9.9.6 BUSINESS SEGMENTS
  7. 9.9.7 GEOGRAPHIC SEGMENTS
  8. 9.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.9.9 PRIMARY MARKET COMPETITORS
19. 9.10 NIKKISO CO., LTD.
20. 1. 9.10.1 COMPANY OVERVIEW
  2. 9.10.2 COMPANY SNAPSHOT
  3. 9.10.3 OPERATING BUSINESS SEGMENTS
  4. 9.10.4 PRODUCT PORTFOLIO
  5. 9.10.5 BUSINESS PERFORMANCE
  6. 9.10.6 BUSINESS SEGMENTS
  7. 9.10.7 GEOGRAPHIC SEGMENTS
  8. 9.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.10.9 PRIMARY MARKET COMPETITORS
21. 9.11 DIALIFE SA
22. 1. 9.11.1 COMPANY OVERVIEW
  2. 9.11.2 COMPANY SNAPSHOT
  3. 9.11.3 OPERATING BUSINESS SEGMENTS
  4. 9.11.4 PRODUCT PORTFOLIO
  5. 9.11.5 BUSINESS PERFORMANCE
  6. 9.11.6 BUSINESS SEGMENTS
  7. 9.11.7 GEOGRAPHIC SEGMENTS
  8. 9.11.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.11.9 PRIMARY MARKET COMPETITORS

1. 9.12 ROCKWELL MEDICAL, INC.
2. 1. 9.12.1 COMPANY OVERVIEW
  2. 9.12.2 COMPANY SNAPSHOT
  3. 9.12.3 OPERATING BUSINESS SEGMENTS
  4. 9.12.4 PRODUCT PORTFOLIO
  5. 9.12.5 BUSINESS PERFORMANCE
  6. 9.12.6 BUSINESS SEGMENTS
  7. 9.12.7 GEOGRAPHIC SEGMENTS
  8. 9.12.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.12.9 PRIMARY MARKET COMPETITORS
3. 9.13 W. L. GORE AND ASSOCIATES, INC.
4. 1. 9.13.1 COMPANY OVERVIEW
  2. 9.13.2 COMPANY SNAPSHOT
  3. 9.13.3 OPERATING BUSINESS SEGMENTS
  4. 9.13.4 PRODUCT PORTFOLIO
  5. 9.13.5 BUSINESS PERFORMANCE
  6. 9.13.6 BUSINESS SEGMENTS
  7. 9.13.7 GEOGRAPHIC SEGMENTS
  8. 9.13.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.13.9 PRIMARY MARKET COMPETITORS
5. 9.14 QUANTA DIALYSIS TECHNOLOGIES LTD.
6. 1. 9.14.1 COMPANY OVERVIEW
  2. 9.14.2 COMPANY SNAPSHOT
  3. 9.14.3 OPERATING BUSINESS SEGMENTS
  4. 9.14.4 PRODUCT PORTFOLIO
  5. 9.14.5 BUSINESS PERFORMANCE
  6. 9.14.6 BUSINESS SEGMENTS
  7. 9.14.7 GEOGRAPHIC SEGMENTS
  8. 9.14.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.14.9 PRIMARY MARKET COMPETITORS
7. 9.15 OUTSET MEDICAL, INC.
8. 1. 9.15.1 COMPANY OVERVIEW
  2. 9.15.2 COMPANY SNAPSHOT
  3. 9.15.3 OPERATING BUSINESS SEGMENTS
  4. 9.15.4 PRODUCT PORTFOLIO
  5. 9.15.5 BUSINESS PERFORMANCE
  6. 9.15.6 BUSINESS SEGMENTS
  7. 9.15.7 GEOGRAPHIC SEGMENTS
  8. 9.15.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.15.9 PRIMARY MARKET COMPETITORS
9. 9.16 SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD.
10. 1. 9.16.1 COMPANY OVERVIEW
  2. 9.16.2 COMPANY SNAPSHOT
  3. 9.16.3 OPERATING BUSINESS SEGMENTS
  4. 9.16.4 PRODUCT PORTFOLIO
  5. 9.16.5 BUSINESS PERFORMANCE
  6. 9.16.6 BUSINESS SEGMENTS
  7. 9.16.7 GEOGRAPHIC SEGMENTS
  8. 9.16.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.16.9 PRIMARY MARKET COMPETITORS
11. 9.17 JMS CO., LTD.
12. 1. 9.17.1 COMPANY OVERVIEW
  2. 9.17.2 COMPANY SNAPSHOT
  3. 9.17.3 OPERATING BUSINESS SEGMENTS
  4. 9.17.4 PRODUCT PORTFOLIO
  5. 9.17.5 BUSINESS PERFORMANCE
  6. 9.17.6 BUSINESS SEGMENTS
  7. 9.17.7 GEOGRAPHIC SEGMENTS
  8. 9.17.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.17.9 PRIMARY MARKET COMPETITORS
13. 9.18 MEDIVATORS INC.
14. 1. 9.18.1 COMPANY OVERVIEW
  2. 9.18.2 COMPANY SNAPSHOT
  3. 9.18.3 OPERATING BUSINESS SEGMENTS
  4. 9.18.4 PRODUCT PORTFOLIO
  5. 9.18.5 BUSINESS PERFORMANCE
  6. 9.18.6 BUSINESS SEGMENTS
  7. 9.18.7 GEOGRAPHIC SEGMENTS
  8. 9.18.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.18.9 PRIMARY MARKET COMPETITORS
15. 9.19 TERUMO CORPORATION
16. 1. 9.19.1 COMPANY OVERVIEW
  2. 9.19.2 COMPANY SNAPSHOT
  3. 9.19.3 OPERATING BUSINESS SEGMENTS
  4. 9.19.4 PRODUCT PORTFOLIO
  5. 9.19.5 BUSINESS PERFORMANCE
  6. 9.19.6 BUSINESS SEGMENTS
  7. 9.19.7 GEOGRAPHIC SEGMENTS
  8. 9.19.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.19.9 PRIMARY MARKET COMPETITORS
17. 9.20 SWS HEMODIALYSIS CARE CO., LTD.
18. 1. 9.20.1 COMPANY OVERVIEW
  2. 9.20.2 COMPANY SNAPSHOT
  3. 9.20.3 OPERATING BUSINESS SEGMENTS
  4. 9.20.4 PRODUCT PORTFOLIO
  5. 9.20.5 BUSINESS PERFORMANCE
  6. 9.20.6 BUSINESS SEGMENTS
  7. 9.20.7 GEOGRAPHIC SEGMENTS
  8. 9.20.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.20.9 PRIMARY MARKET COMPETITORS

TABLE 1. GLOBAL DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 2. HEMODIALYSIS (HD) MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
TABLE 3. NORTH AMERICA HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 4. EUROPE HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 5. ASIA-PACIFIC HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 6. REST OF THE WORLD HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 7. PERITONEAL DIALYSIS (PD) MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
TABLE 8. NORTH AMERICA PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 9. EUROPE PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 10. ASIA-PACIFIC PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 11. REST OF THE WORLD PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 12. GLOBAL DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 13. HOSPITALS MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
TABLE 14. NORTH AMERICA HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 15. EUROPE HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 16. ASIA-PACIFIC HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 17. REST OF THE WORLD HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 18. DIALYSIS CENTERS MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
TABLE 19. NORTH AMERICA DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 20. EUROPE DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 21. ASIA-PACIFIC DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 22. REST OF THE WORLD DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 23. HOMECARE MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
TABLE 24. NORTH AMERICA HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 25. EUROPE HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 26. ASIA-PACIFIC HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 27. REST OF THE WORLD HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 28. AMBULATORY SURGICAL CENTERS MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
TABLE 29. NORTH AMERICA AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 30. EUROPE AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 31. ASIA-PACIFIC AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 32. REST OF THE WORLD AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 33. GLOBAL DIALYSIS MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
TABLE 34. NORTH AMERICA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 35. NORTH AMERICA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 36. UNITED STATES DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 37. UNITED STATES DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 38. CANADA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 39. CANADA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 40. MEXICO DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 41. MEXICO DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 42. EUROPE DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 43. EUROPE DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 44. GERMANY DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 45. GERMANY DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 46. FRANCE DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 47. FRANCE DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 48. ITALY DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 49. ITALY DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 50. SPAIN DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 51. SPAIN DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 52. UNITED KINGDOM DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 53. UNITED KINGDOM DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 54. RUSSIA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 55. RUSSIA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 56. SWITZERLAND DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 57. SWITZERLAND DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 58. SWEDEN DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 59. SWEDEN DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 60. NORWAY DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 61. NORWAY DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 62. DENMARK DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 63. DENMARK DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 64. FINLAND DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 65. FINLAND DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 66. REST OF EUROPE DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 67. REST OF EUROPE DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 68. ASIA-PACIFIC DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 69. ASIA-PACIFIC DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 70. AUSTRALIA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 71. AUSTRALIA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 72. CHINA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 73. CHINA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 74. INDIA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 75. INDIA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 76. JAPAN DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 77. JAPAN DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 78. SOUTH KOREA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 79. SOUTH KOREA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 80. INDONESIA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 81. INDONESIA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 82. SINGAPORE DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 83. SINGAPORE DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 84. TAIWAN DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 85. TAIWAN DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 86. THAILAND DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 87. THAILAND DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 88. REST OF ASIA-PACIFIC DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 89. REST OF ASIA-PACIFIC DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 90. REST OF THE WORLD DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 91. REST OF THE WORLD DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 92. LATIN AMERICA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 93. LATIN AMERICA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 94. MIDDLE EAST DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 95. MIDDLE EAST DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 96. AFRICA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 97. AFRICA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 98. FRESENIUS MEDICAL CARE AG AND CO. KGAA: COMPANY SNAPSHOT
TABLE 99. FRESENIUS MEDICAL CARE AG AND CO. KGAA: OPERATING BUSINESS SEGMENTS
TABLE 100. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRODUCT PORTFOLIO
TABLE 101. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 102. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 103. FRESENIUS MEDICAL CARE AG AND CO. KGAA: KEY STRATERGY
TABLE 104. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 105. BAXTER INTERNATIONAL INC.: OPERATING BUSINESS SEGMENTS
TABLE 106. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 107. BAXTER INTERNATIONAL INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 108. BAXTER INTERNATIONAL INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 109. BAXTER INTERNATIONAL INC.: KEY STRATERGY
TABLE 110. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 111. B. BRAUN MELSUNGEN AG: OPERATING BUSINESS SEGMENTS
TABLE 112. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 113. B. BRAUN MELSUNGEN AG: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 114. B. BRAUN MELSUNGEN AG: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 115. B. BRAUN MELSUNGEN AG: KEY STRATERGY
TABLE 116. NIPRO CORPORATION: COMPANY SNAPSHOT
TABLE 117. NIPRO CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 118. NIPRO CORPORATION: PRODUCT PORTFOLIO
TABLE 119. NIPRO CORPORATION: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 120. NIPRO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 121. NIPRO CORPORATION: KEY STRATERGY
TABLE 122. ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
TABLE 123. ASAHI KASEI CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 124. ASAHI KASEI CORPORATION: PRODUCT PORTFOLIO
TABLE 125. ASAHI KASEI CORPORATION: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 126. ASAHI KASEI CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 127. ASAHI KASEI CORPORATION: KEY STRATERGY
TABLE 128. BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
TABLE 129. BECTON, DICKINSON AND COMPANY (BD): OPERATING BUSINESS SEGMENTS
TABLE 130. BECTON, DICKINSON AND COMPANY (BD): PRODUCT PORTFOLIO
TABLE 131. BECTON, DICKINSON AND COMPANY (BD): SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 132. BECTON, DICKINSON AND COMPANY (BD): SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 133. BECTON, DICKINSON AND COMPANY (BD): KEY STRATERGY
TABLE 134. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 135. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS
TABLE 136. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 137. MEDTRONIC PLC: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 138. MEDTRONIC PLC: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 139. MEDTRONIC PLC: KEY STRATERGY
TABLE 140. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
TABLE 141. TELEFLEX INCORPORATED: OPERATING BUSINESS SEGMENTS
TABLE 142. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
TABLE 143. TELEFLEX INCORPORATED: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 144. TELEFLEX INCORPORATED: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 145. TELEFLEX INCORPORATED: KEY STRATERGY
TABLE 146. TORAY MEDICAL CO., LTD. (TORAY INDUSTRIES, INC.): COMPANY SNAPSHOT
TABLE 147. TORAY MEDICAL CO., LTD. (TORAY INDUSTRIES, INC.): OPERATING BUSINESS SEGMENTS
TABLE 148. TORAY MEDICAL CO., LTD. (TORAY INDUSTRIES, INC.): PRODUCT PORTFOLIO
TABLE 149. TORAY MEDICAL CO., LTD. (TORAY INDUSTRIES, INC.): SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 150. TORAY MEDICAL CO., LTD. (TORAY INDUSTRIES, INC.): SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 151. TORAY MEDICAL CO., LTD. (TORAY INDUSTRIES, INC.): KEY STRATERGY
TABLE 152. NIKKISO CO., LTD.: COMPANY SNAPSHOT
TABLE 153. NIKKISO CO., LTD.: OPERATING BUSINESS SEGMENTS
TABLE 154. NIKKISO CO., LTD.: PRODUCT PORTFOLIO
TABLE 155. NIKKISO CO., LTD.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 156. NIKKISO CO., LTD.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 157. NIKKISO CO., LTD.: KEY STRATERGY
TABLE 158. DIALIFE SA: COMPANY SNAPSHOT
TABLE 159. DIALIFE SA: OPERATING BUSINESS SEGMENTS
TABLE 160. DIALIFE SA: PRODUCT PORTFOLIO
TABLE 161. DIALIFE SA: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 162. DIALIFE SA: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 163. DIALIFE SA: KEY STRATERGY
TABLE 164. ROCKWELL MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 165. ROCKWELL MEDICAL, INC.: OPERATING BUSINESS SEGMENTS
TABLE 166. ROCKWELL MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 167. ROCKWELL MEDICAL, INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 168. ROCKWELL MEDICAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 169. ROCKWELL MEDICAL, INC.: KEY STRATERGY
TABLE 170. W. L. GORE AND ASSOCIATES, INC.: COMPANY SNAPSHOT
TABLE 171. W. L. GORE AND ASSOCIATES, INC.: OPERATING BUSINESS SEGMENTS
TABLE 172. W. L. GORE AND ASSOCIATES, INC.: PRODUCT PORTFOLIO
TABLE 173. W. L. GORE AND ASSOCIATES, INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 174. W. L. GORE AND ASSOCIATES, INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 175. W. L. GORE AND ASSOCIATES, INC.: KEY STRATERGY
TABLE 176. QUANTA DIALYSIS TECHNOLOGIES LTD.: COMPANY SNAPSHOT
TABLE 177. QUANTA DIALYSIS TECHNOLOGIES LTD.: OPERATING BUSINESS SEGMENTS
TABLE 178. QUANTA DIALYSIS TECHNOLOGIES LTD.: PRODUCT PORTFOLIO
TABLE 179. QUANTA DIALYSIS TECHNOLOGIES LTD.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 180. QUANTA DIALYSIS TECHNOLOGIES LTD.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 181. QUANTA DIALYSIS TECHNOLOGIES LTD.: KEY STRATERGY
TABLE 182. OUTSET MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 183. OUTSET MEDICAL, INC.: OPERATING BUSINESS SEGMENTS
TABLE 184. OUTSET MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 185. OUTSET MEDICAL, INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 186. OUTSET MEDICAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 187. OUTSET MEDICAL, INC.: KEY STRATERGY
TABLE 188. SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD.: COMPANY SNAPSHOT
TABLE 189. SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD.: OPERATING BUSINESS SEGMENTS
TABLE 190. SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD.: PRODUCT PORTFOLIO
TABLE 191. SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 192. SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 193. SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD.: KEY STRATERGY
TABLE 194. JMS CO., LTD.: COMPANY SNAPSHOT
TABLE 195. JMS CO., LTD.: OPERATING BUSINESS SEGMENTS
TABLE 196. JMS CO., LTD.: PRODUCT PORTFOLIO
TABLE 197. JMS CO., LTD.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 198. JMS CO., LTD.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 199. JMS CO., LTD.: KEY STRATERGY
TABLE 200. MEDIVATORS INC.: COMPANY SNAPSHOT
TABLE 201. MEDIVATORS INC.: OPERATING BUSINESS SEGMENTS
TABLE 202. MEDIVATORS INC.: PRODUCT PORTFOLIO
TABLE 203. MEDIVATORS INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 204. MEDIVATORS INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 205. MEDIVATORS INC.: KEY STRATERGY
TABLE 206. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 207. TERUMO CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 208. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 209. TERUMO CORPORATION: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 210. TERUMO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 211. TERUMO CORPORATION: KEY STRATERGY
TABLE 212. SWS HEMODIALYSIS CARE CO., LTD.: COMPANY SNAPSHOT
TABLE 213. SWS HEMODIALYSIS CARE CO., LTD.: OPERATING BUSINESS SEGMENTS
TABLE 214. SWS HEMODIALYSIS CARE CO., LTD.: PRODUCT PORTFOLIO
TABLE 215. SWS HEMODIALYSIS CARE CO., LTD.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 216. SWS HEMODIALYSIS CARE CO., LTD.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 217. SWS HEMODIALYSIS CARE CO., LTD.: KEY STRATERGY

FIGURE 1. BARGAINING POWER OF SUPPLIERS
FIGURE 2. BARGAINING POWER OF BUYERS
FIGURE 3. DEGREE OF COMPETITION
FIGURE 4. THREAT OF SUBSTITUTE
FIGURE 5. THREAT OF NEW ENTRANTS
FIGURE 6. GLOBAL DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
FIGURE 7. HEMODIALYSIS (HD) MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
FIGURE 8. NORTH AMERICA HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 9. EUROPE HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 10. ASIA-PACIFIC HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 11. REST OF THE WORLD HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 12. PERITONEAL DIALYSIS (PD) MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
FIGURE 13. NORTH AMERICA PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 14. EUROPE PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 15. ASIA-PACIFIC PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 16. REST OF THE WORLD PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 17. GLOBAL DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
FIGURE 18. HOSPITALS MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
FIGURE 19. NORTH AMERICA HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 20. EUROPE HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 21. ASIA-PACIFIC HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 22. REST OF THE WORLD HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 23. DIALYSIS CENTERS MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
FIGURE 24. NORTH AMERICA DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 25. EUROPE DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 26. ASIA-PACIFIC DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 27. REST OF THE WORLD DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 28. HOMECARE MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
FIGURE 29. NORTH AMERICA HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 30. EUROPE HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 31. ASIA-PACIFIC HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 32. REST OF THE WORLD HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 33. AMBULATORY SURGICAL CENTERS MARKET VALUE, BY REGION, 2024-2030, (BILLION USD)
FIGURE 34. NORTH AMERICA AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 35. EUROPE AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 36. ASIA-PACIFIC AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 37. REST OF THE WORLD AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 38. GLOBAL DIALYSIS MARKET VALUE, BY REGION 2024-2030, (BILLION USD)
FIGURE 39. NORTH AMERICA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 40. NORTH AMERICA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 41. UNITED STATES DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 42. UNITED STATES DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 43. CANADA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 44. CANADA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 45. MEXICO DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 46. MEXICO DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 47. EUROPE DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 48. EUROPE DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 49. GERMANY DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 50. GERMANY DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 51. FRANCE DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 52. FRANCE DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 53. ITALY DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 54. ITALY DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 55. SPAIN DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 56. SPAIN DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 57. UNITED KINGDOM DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 58. UNITED KINGDOM DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 59. RUSSIA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 60. RUSSIA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 61. SWITZERLAND DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 62. SWITZERLAND DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 63. SWEDEN DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 64. SWEDEN DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 65. NORWAY DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 66. NORWAY DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 67. DENMARK DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 68. DENMARK DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 69. FINLAND DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 70. FINLAND DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 71. REST OF EUROPE DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 72. REST OF EUROPE DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 73. ASIA-PACIFIC DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 74. ASIA-PACIFIC DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 75. AUSTRALIA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 76. AUSTRALIA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 77. CHINA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 78. CHINA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 79. INDIA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 80. INDIA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 81. JAPAN DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 82. JAPAN DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 83. SOUTH KOREA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 84. SOUTH KOREA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 85. INDONESIA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 86. INDONESIA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 87. SINGAPORE DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 88. SINGAPORE DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 89. TAIWAN DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 90. TAIWAN DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 91. THAILAND DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 92. THAILAND DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 93. REST OF ASIA-PACIFIC DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 94. REST OF ASIA-PACIFIC DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 95. REST OF THE WORLD DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 96. REST OF THE WORLD DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 97. LATIN AMERICA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 98. LATIN AMERICA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 99. MIDDLE EAST DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 100. MIDDLE EAST DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 101. AFRICA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 102. AFRICA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 103. FRESENIUS MEDICAL CARE AG AND CO. KGAA: NET SALES, (2022-2024)
FIGURE 104. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRIMARY MARKET COMPETITORS
FIGURE 105. BAXTER INTERNATIONAL INC.: NET SALES, (2022-2024)
FIGURE 106. BAXTER INTERNATIONAL INC.: PRIMARY MARKET COMPETITORS
FIGURE 107. B. BRAUN MELSUNGEN AG: NET SALES, (2022-2024)
FIGURE 108. B. BRAUN MELSUNGEN AG: PRIMARY MARKET COMPETITORS
FIGURE 109. NIPRO CORPORATION: NET SALES, (2022-2024)
FIGURE 110. NIPRO CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 111. ASAHI KASEI CORPORATION: NET SALES, (2022-2024)
FIGURE 112. ASAHI KASEI CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 113. BECTON, DICKINSON AND COMPANY (BD): NET SALES, (2022-2024)
FIGURE 114. BECTON, DICKINSON AND COMPANY (BD): PRIMARY MARKET COMPETITORS
FIGURE 115. MEDTRONIC PLC: NET SALES, (2022-2024)
FIGURE 116. MEDTRONIC PLC: PRIMARY MARKET COMPETITORS
FIGURE 117. TELEFLEX INCORPORATED: NET SALES, (2022-2024)
FIGURE 118. TELEFLEX INCORPORATED: PRIMARY MARKET COMPETITORS
FIGURE 119. TORAY MEDICAL CO., LTD. (TORAY INDUSTRIES, INC.): NET SALES, (2022-2024)
FIGURE 120. TORAY MEDICAL CO., LTD. (TORAY INDUSTRIES, INC.): PRIMARY MARKET COMPETITORS
FIGURE 121. NIKKISO CO., LTD.: NET SALES, (2022-2024)
FIGURE 122. NIKKISO CO., LTD.: PRIMARY MARKET COMPETITORS
FIGURE 123. DIALIFE SA: NET SALES, (2022-2024)
FIGURE 124. DIALIFE SA: PRIMARY MARKET COMPETITORS
FIGURE 125. ROCKWELL MEDICAL, INC.: NET SALES, (2022-2024)
FIGURE 126. ROCKWELL MEDICAL, INC.: PRIMARY MARKET COMPETITORS
FIGURE 127. W. L. GORE AND ASSOCIATES, INC.: NET SALES, (2022-2024)
FIGURE 128. W. L. GORE AND ASSOCIATES, INC.: PRIMARY MARKET COMPETITORS
FIGURE 129. QUANTA DIALYSIS TECHNOLOGIES LTD.: NET SALES, (2022-2024)
FIGURE 130. QUANTA DIALYSIS TECHNOLOGIES LTD.: PRIMARY MARKET COMPETITORS
FIGURE 131. OUTSET MEDICAL, INC.: NET SALES, (2022-2024)
FIGURE 132. OUTSET MEDICAL, INC.: PRIMARY MARKET COMPETITORS
FIGURE 133. SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD.: NET SALES, (2022-2024)
FIGURE 134. SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO., LTD.: PRIMARY MARKET COMPETITORS
FIGURE 135. JMS CO., LTD.: NET SALES, (2022-2024)
FIGURE 136. JMS CO., LTD.: PRIMARY MARKET COMPETITORS
FIGURE 137. MEDIVATORS INC.: NET SALES, (2022-2024)
FIGURE 138. MEDIVATORS INC.: PRIMARY MARKET COMPETITORS
FIGURE 139. TERUMO CORPORATION: NET SALES, (2022-2024)
FIGURE 140. TERUMO CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 141. SWS HEMODIALYSIS CARE CO., LTD.: NET SALES, (2022-2024)
FIGURE 142. SWS HEMODIALYSIS CARE CO., LTD.: PRIMARY MARKET COMPETITORS

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

SWOT Analysis

We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.

Frequently Asked Questions

The top companies operating in the Dialysis Market Fresenius Medical Care AG And Co. KGaA, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation., Asahi Kasei Corporation, Becton, Dickinson and Company (BD), Medtronic Plc, Teleflex Incorporated, Toray Medical Co., Ltd. (Toray Industries, Inc.), Nikkiso Co., Ltd., Dialife SA,, Rockwell Medical, Inc. W. L. Gore and Associates, Inc., Quanta Dialysis Technologies Ltd., Outset Medical, Inc., Shandong Weigao Blood Purification Products Co., Ltd., JMS Co., Ltd., Medivators Inc., Terumo Corporation, SWS Hemodialysis Care Co., Ltd., and others.

According to projections from Next Move Strategy Consulting, the global Dialysis Market is anticipated to reach USD 145.15 billion by 2030.

The significant challenges in the Dialysis Market are the increasing demand for dialysis services along with limited awareness among individuals.

North America is the dominant region in the Dialysis Market, driven by advanced healthcare infrastructure and a high prevalence of chronic kidney diseases.

The global Dialysis Market was valued at USD 113.32 billion in 2023, as per the findings of Next Move Strategy Consulting's report, reflecting substantial growth from the 2022 value of USD 6.1 Billion.

Download Free Sample

Phone Number *

Please enter Country Code and Phone No

Yes, I have read the Privacy Policy

Multi User

$4,975

Single User

$3,975

Enterprise

$6,975

Datapack

$2,975

Download Sample

Inquire Before Buying